ABSTRACT
PURPOSE: Increasing evidence suggested that microRNA plays an important role in ovarian cancer. In this study, the role of miR-92 in ovarian cancer was investigated. METHODS: In this study, miR-92 expression in clinical sample was evaluated, role of miR-92 was investigated in vitro, and underlying mechanism was investigated using Chip, co-IP, and western blot. RESULTS: In this study, we show that miR-92 is overexpressed in ovarian cancer tissue compared with normal cancer tissue. Transfection of miR-92 increased proliferation of ovarian cancer cell, and increased migration capacity and colony formation were observed after miR-92 transfection; we found that expression of LATS2 was decreased by miR-92, and this was further confirmed by luciferase assay, which proved that miR-92 is targeting 3' of the endogenous LATS2 gene. Downregulation of LATS2 resulted in increased translocation of YAP1 and upregulation of PD-L1, which subsequently suppressed NK cell function and promoted T cell apoptosis. Moreover, co-transfection of YAP1-targeted shRNA could relieve miR-92-induced immune suppression effect. Mechanically, immunoprecipitation (IP) was used to show that LATS2 interacted with YAP1 and subsequently limited nuclear translocation of YAP1; chromatin immunoprecipitation (ChIP) was used to confirm that YAP1 could bind to enhancer region of PD-L1 to enhance transcription activity of PD-L1. CONCLUSIONS: Our data revealed a novel mechanism which finally resulted in immune suppression in ovarian cancer.
Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , B7-H1 Antigen/metabolism , Killer Cells, Natural/immunology , MicroRNAs/metabolism , Ovarian Neoplasms/immunology , Protein Serine-Threonine Kinases/metabolism , Transcription Factors/metabolism , Tumor Suppressor Proteins/metabolism , Apoptosis , Cell Line, Tumor , Cell Movement , Cell Nucleus/metabolism , Cell Proliferation , Down-Regulation , Enhancer Elements, Genetic , Female , Gene Silencing , Humans , Immunity, Cellular , Immunoprecipitation , Neoplastic Stem Cells , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Protein Serine-Threonine Kinases/genetics , RNA, Small Interfering , Signal Transduction , T-Lymphocytes/physiology , Tumor Suppressor Proteins/genetics , Up-Regulation , YAP-Signaling ProteinsABSTRACT
The human thymus suffers a transient neonatal involution, recovers and then starts a process of decline between the 1st and 2nd years of life. Age-related morphological changes in thymus were extensively investigated, but the genomic mechanisms underlying this process remain largely unknown. Through Weighted Gene Co-expression Network Analysis (WGCNA) and TF-miRNA-mRNA integrative analysis we studied the transcriptome of neonate and infant thymic tissues grouped by age: 0-30 days (A); 31days-6 months (B); 7-12 months (C); 13-18 months (D); 19-31months (E). Age-related transcriptional modules, hubs and high gene significance (HGS) genes were identified, as well as TF-miRNA-hub/HGS co-expression correlations. Three transcriptional modules were correlated with A and/or E groups. Hubs were mostly related to cellular/metabolic processes; few were differentially expressed (DE) or related to T-cell development. Inversely, HGS genes in groups A and E were mostly DE. In A (neonate) one third of the hyper-expressed HGS genes were related to T-cell development, against one-twentieth in E, what may correlate with the early neonatal depletion and recovery of thymic T-cell populations. This genomic mechanism is tightly regulated by TF-miRNA-hub/HGS interactions that differentially govern cellular and molecular processes involved in the functioning of the neonate thymus and in the beginning of thymic decline.
Subject(s)
Gene Expression Regulation, Developmental , Gene Regulatory Networks , T-Lymphocytes/physiology , Thymus Gland/growth & development , Age Factors , Cell Differentiation/genetics , Child, Preschool , Female , Gene Expression Profiling , Humans , Infant , Infant, Newborn , Male , MicroRNAs/genetics , MicroRNAs/metabolism , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sex Factors , Thymus Gland/surgery , Transcription Factors/genetics , Transcription Factors/metabolismABSTRACT
Trypanosoma cruzi is a protozoan parasite that infects at least 7 million persons in the world (OMS, 2019). In endemic areas, infection normally occurs by vectorial transmission; however, outside, it normally happens by blood and includes congenital transmission. The persistence of T. cruzi during infection suggests the presence of immune evasion mechanisms and the modulation of the anti-parasite response to a profile incapable of eradicating the parasite. Dendritic cells (DCs) are a heterogeneous population of antigen-presenting cells (APCs) that patrol tissues with a key role in mediating the interface between the innate and adaptive immune response. Previous results from our lab and other groups have demonstrated that T. cruzi modulates the functional properties of DCs, in vitro and in vivo. During vectorial transmission, metacyclic (m) trypomastigotes (Tps) eliminated along with the insect feces reach the mucous membranes or injured skin. When transmission occurs by the hematic route, the parasite stage involved in the infection is the circulating or blood (b) Tp. Here, we studied in vitro the effect of both infective mTp and bTp in two different populations of DCs, bone marrow-derived DCs (BMDCs) and XS106, a cell line derived from epidermal DCs. Results demonstrated that the interaction of both Tps imparts a different effect in the functionality of these two populations of DCs, suggesting that the stage of T. cruzi and DC maturation status could define the immune response from the beginning of the ingress of the parasite, conditioning the course of the infection.
Subject(s)
Dendritic Cells/immunology , Langerhans Cells/immunology , Trypanosoma cruzi/physiology , Animals , Antigen Presentation , Cell Line , Cell Proliferation , Dendritic Cells/metabolism , Dendritic Cells/parasitology , Interleukin-10/metabolism , Langerhans Cells/metabolism , Langerhans Cells/parasitology , Mice, Inbred C3H , Mice, Inbred C57BL , T-Lymphocytes/physiology , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/pathogenicity , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Healthy aging is partly related to appropriate function of the immune system. As already reported, some changes in this system are observed, including reduced number and repertoire of T cells due to thymic involution, accumulation of memory T cells by chronic infections, homeostatic proliferation compensating for the number of naïve T cells, decreased proliferation of T cells against a stimulus, telomere shortening, replicative senescence of the T cells, and inflammaging, besides the accumulation of myeloid-derived suppressor cells. The purpose of this article is to clarify each of these changes, aiming to minimize limitations of immunosenescence. If such associations can be established, these cells may be used as early and less invasive markers of aging-related diseases, as well as to indicate interventions, evaluate the efficacy of interventions and be a tool to achieve longevity with quality of life.
Subject(s)
Aging/immunology , Immunosenescence/immunology , Myeloid-Derived Suppressor Cells/physiology , T-Lymphocytes/physiology , Adaptation, Physiological/immunology , Cell Proliferation/physiology , HumansABSTRACT
Abstract Objective To describe the immunological and hematological reference intervals of low-risk pregnant women. Methods A cross-sectional retrospective database analysis of a basic and translational study analyzing the hematological evaluation blood counts and immunophenotyping of TCD3 + , TCD4 + , TCD8 + , B, and natural killer (NK) cells of the peripheral blood in 79 low-risk pregnant women and of 30 control women from the state of Pernambuco, Brazil, was performed. Results No significant differences were detected between the hematological profiles of the 2nd and 3rd trimesters. Nevertheless, the median level of B cells decreased significantly in the 2nd (174 x 103 μL; p < 0.002) and 3rd trimesters (160 x 103 μL; p < 0.001), compared with the control group (296 x 103 μL). Similarly, the median level of NK cells was lower in the 2nd (134 x 103 μL; p < 0.0004) and 3rd trimesters (100 x 103 μL, p < 0.0004), compared with the control group (183 x 103 μL). In contrast, relative TCD4+ and TCD8+ levels increased in the 2nd and 3rd trimesters compared with the controls (TCD4 + : 2nd trimester = 59%; p < 0.001; 3rd trimester = 57%; p < 0.01; control = 50%; and TCD8 + : 2nd trimester = 31%; p < 0.001; 3rd trimester = 36%; p < 0.01; control = 24%). Conclusion Low-risk pregnant women have ~ 40% less B and NK cells in the peripheral blood, compared with non-pregnant women. These parameters may improve health assistance for mothers and contribute to define reference values for normal pregnancies.
Resumo Objetivo Descrever o intervalo de referência imunológico e hematológico de gestantes de baixo risco. Métodos Realizou-se uma análise retrospectiva, de um estudo básico e translacional, analisando o perfil hematológico e a imunofenotipagem das células TCD3 + , TCD4 + , TCD8 + , B e natural killer (NK) do sangue periférico de 79 gestantes de baixo risco e de 30 mulheres (controles) do estado de Pernambuco, Brasil. Resultados Não observamos diferenças significativas entre os perfis hematológicos do 2° e 3° trimestres. No entanto, houve redução das células B no 2° (média = 174 x 103 μL; p < 0,002) e no 3° trimestres (160 x 103 μL; p < 0,001), comparado como grupo controle (296 x 103 μL). A mediana das células NK foi menor no 2° (134 x 103 μL; p < 0,0004) e no 3° trimestres (100 x 103 μL; p < 0,0004), comparado com o grupo controle (183 x 103 μL). Porém, o percentual de TCD4+ e de TCD8+ aumentou no 2° e 3° trimestres em relação aos controles (TCD4 + : 2° trimestre = 59%; p < 0,001; 3° trimestre = 57%; p < 0,01; controle = 50%; e TCD8 + : 2° trimestre = 31%; p < 0,001; 3° trimestre = 36%; p < 0,01; controle = 24%). Conclusão Mulheres grávidas de baixo risco têm ~ 40% menos células B e NK no sangue periférico em comparação com mulheres não grávidas. Estes parâmetros podem melhorar a assistência à saúde das mães e contribuir para a definição de valores de referência para gestações normais.
Subject(s)
Humans , Female , Adolescent , Adult , Young Adult , Pregnancy/immunology , Killer Cells, Natural/physiology , T-Lymphocytes/physiology , Pregnancy Trimesters , Reference Values , Pregnancy/blood , Cross-Sectional Studies , Retrospective Studies , Databases, FactualABSTRACT
OBJECTIVE: To describe the immunological and hematological reference intervals of low-risk pregnant women. METHODS: A cross-sectional retrospective database analysis of a basic and translational study analyzing the hematological evaluation blood counts and immunophenotyping of TCD3 + , TCD4 + , TCD8 + , B, and natural killer (NK) cells of the peripheral blood in 79 low-risk pregnant women and of 30 control women from the state of Pernambuco, Brazil, was performed. RESULTS: No significant differences were detected between the hematological profiles of the 2nd and 3rd trimesters. Nevertheless, the median level of B cells decreased significantly in the 2nd (174 × 103 µL; p < 0.002) and 3rd trimesters (160 × 103 µL; p < 0.001), compared with the control group (296 × 103 µL). Similarly, the median level of NK cells was lower in the 2nd (134 × 103 µL; p < 0.0004) and 3rd trimesters (100 × 103 µL, p < 0.0004), compared with the control group (183 × 103 µL). In contrast, relative TCD4+ and TCD8+ levels increased in the 2nd and 3rd trimesters compared with the controls (TCD4 + : 2nd trimester = 59%; p < 0.001; 3rd trimester = 57%; p < 0.01; control = 50%; and TCD8 + : 2nd trimester = 31%; p < 0.001; 3rd trimester = 36%; p < 0.01; control = 24%). CONCLUSION: Low-risk pregnant women have â¼ 40% less B and NK cells in the peripheral blood, compared with non-pregnant women. These parameters may improve health assistance for mothers and contribute to define reference values for normal pregnancies.
OBJETIVO: Descrever o intervalo de referência imunológico e hematológico de gestantes de baixo risco. MéTODOS: Realizou-se uma análise retrospectiva, de um estudo básico e translacional, analisando o perfil hematológico e a imunofenotipagem das células TCD3 + , TCD4 + , TCD8 + , B e natural killer (NK) do sangue periférico de 79 gestantes de baixo risco e de 30 mulheres (controles) do estado de Pernambuco, Brasil. RESULTADOS: Não observamos diferenças significativas entre os perfis hematológicos do 2° e 3° trimestres. No entanto, houve redução das células B no 2° (média = 174 × 103 µL; p < 0,002) e no 3° trimestres (160 × 103 µL; p < 0,001), comparado com o grupo controle (296 × 103 µL). A mediana das células NK foi menor no 2° (134 × 103 µL; p < 0,0004) e no 3° trimestres (100 × 103 µL; p < 0,0004), comparado com o grupo controle (183 × 103 µL). Porém, o percentual de TCD4+ e de TCD8+ aumentou no 2° e 3° trimestres em relação aos controles (TCD4 + : 2° trimestre = 59%; p < 0,001; 3° trimestre = 57%; p < 0,01; controle = 50%; e TCD8 + : 2° trimestre = 31%; p < 0,001; 3° trimestre = 36%; p < 0,01; controle = 24%). CONCLUSãO: Mulheres grávidas de baixo risco têm â¼ 40% menos células B e NK no sangue periférico em comparação com mulheres não grávidas. Estes parâmetros podem melhorar a assistência à saúde das mães e contribuir para a definição de valores de referência para gestações normais.
Subject(s)
Killer Cells, Natural/physiology , Pregnancy/immunology , T-Lymphocytes/physiology , Adolescent , Adult , Cross-Sectional Studies , Databases, Factual , Female , Humans , Pregnancy/blood , Pregnancy Trimesters , Reference Values , Retrospective Studies , Young AdultABSTRACT
BACKGROUND: The del22q11 syndrome patients present immunological abnormalities associated to thymus alterations. Up to 75% of them present cardiopathies and thymus is frequently removed during surgery. The thymectomy per se has a deleterious effect concerning lymphocyte subpopulations, and T cell function. When compared to healthy controls, these patients have higher infections propensity of variable severity. The factors behind these variations are unknown. We compared immunological profiles of del22q11.2 Syndrome patients with and without thymectomy to establish its effect in the immune profile. METHODS: Forty-six del22q11.2 syndrome patients from 1 to 16 years old, 19 of them with partial or total thymectomy were included. Heart disease type, heart surgery, infections events and thymus resection were identified. Immunoglobulin levels, flow cytometry for lymphocytes subpopulations and TREC levels were determined, and statistical analyses were performed. RESULTS: The thymectomy group had a lower lymphocyte index, both regarding total cell count and when comparing age-adjusted Z scores. Also, CD3+, CD4+ and CD8+ lower levels were observed in this group, the lowest count in those patients who had undergone thymus resection during the first year of life. Their TREC level median was 23.6/µL vs 16.1µL in the non-thymus group (p=0.22). No differences were identified regarding immunoglobulin levels or infection events frequencies over the previous year. CONCLUSION: Patients with del22q11.2 syndrome subjected to thymus resection present lower lymphocyte and TREC indexes when compared to patients without thymectomy. This situation may be influenced by the age at the surgery and the time elapsed since the procedure.
Subject(s)
T-Lymphocyte Subsets/physiology , T-Lymphocytes/physiology , Thymectomy , Thymus Gland/surgery , Adolescent , Child , Child, Preschool , Chromosome Deletion , Chromosomes, Human, Pair 22/immunology , Female , Flow Cytometry , Humans , Infant , Lymphocyte Count , Male , Receptors, Antigen, T-Cell/geneticsABSTRACT
ABSTRACT Healthy aging is partly related to appropriate function of the immune system. As already reported, some changes in this system are observed, including reduced number and repertoire of T cells due to thymic involution, accumulation of memory T cells by chronic infections, homeostatic proliferation compensating for the number of naïve T cells, decreased proliferation of T cells against a stimulus, telomere shortening, replicative senescence of the T cells, and inflammaging, besides the accumulation of myeloid-derived suppressor cells. The purpose of this article is to clarify each of these changes, aiming to minimize limitations of immunosenescence. If such associations can be established, these cells may be used as early and less invasive markers of aging-related diseases, as well as to indicate interventions, evaluate the efficacy of interventions and be a tool to achieve longevity with quality of life.
RESUMO O envelhecimento saudável está relacionado, pelo menos em parte, com a função adequada do sistema imunológico. Isso porque já foi relatado que, com o envelhecimento, algumas mudanças desse sistema são observadas, como a diminuição da percentagem e do repertório de células T pela involução tímica, acúmulo de células T de memória por infecções crônicas, compensação do número de células T naïve por proliferação homeostática, diminuição da capacidade de proliferação das células T frente a um estímulo, encurtamento dos telômeros, senescência replicativa das células T, e inflammaging, além do acúmulo de células mieloides supressoras. Este artigo visa esclarecer cada uma das mudanças, mencionadas, com o intuito de buscar meios de minimizar as limitações da imunosenescência. Caso seja possível estabelecer tais relações, essas células podem ser utilizadas como marcadores precoces e pouco invasivos de doenças relacionadas ao envelhecimento, além da possibilidade de serem utilizadas para indicar intervenções, avaliar a eficácia das intervenções e como ferramenta para alcance da longevidade com qualidade de vida.
Subject(s)
Humans , Aging/immunology , T-Lymphocytes/physiology , Immunosenescence/immunology , Myeloid-Derived Suppressor Cells/physiology , Adaptation, Physiological/immunology , Cell Proliferation/physiologyABSTRACT
There has been dramatic success in treating patients with adoptive transfer of autologous T cells genetically modified to express a chimeric antigen receptor redirecting them to the antigen CD19. Despite this success, the application of chimeric antigen receptor T-cell therapy in solid malignancies has encountered many challenges that need to be overcome if similar success across other cancers is to become a reality. These challenges can be classified into 6 categories: the heterogeneity of tumor cell clones and tumor-associated antigen expression; poor T-cell trafficking into the tumor site; poor T-cell survival and persistence; the presence of suppressive immune cells; the secretion of suppressive soluble factors in the tumor microenvironment; and the upregulation of T-cell intrinsic inhibitory pathways. We outline specific representative hurdles in each of these categories and summarize the progress made in understanding them and developing strategies to overcome them.
Subject(s)
Immunotherapy, Adoptive/methods , Neoplasms/therapy , Receptors, Antigen/metabolism , T-Lymphocytes/physiology , Gene Expression Regulation, Neoplastic , Genetic Variation , Humans , Receptors, Antigen/geneticsABSTRACT
Human aging is characterized by both physical and physiological frailty that profoundly affects the immune system. In this context aging is associated with declines in adaptive and innate immunity established as immunosenescence. Immunosenescence is a new concept that reflects the age-associated restructuring changes of innate and adaptive immune functions. Thus elderly individuals usually present chronic low-level inflammation, higher infection rates and chronic diseases. A study of alterations in the immune system during aging could provide a potentially useful biomarker for the evaluation of immune senescence treatment. The immune system is the result of the interplay between innate and adaptive immunity, yet the impact of aging on this function is unclear. In this article the function of the immune system during aging is explored.
Subject(s)
Immune System Diseases/physiopathology , Immune System/physiopathology , Immunosenescence/immunology , Immunosenescence/physiology , Age Factors , Aged , Aged, 80 and over , Humans , T-Lymphocytes/physiologyABSTRACT
ABSTRACT Human aging is characterized by both physical and physiological frailty that profoundly affects the immune system. In this context aging is associated with declines in adaptive and innate immunity established as immunosenescence. Immunosenescence is a new concept that reflects the age-associated restructuring changes of innate and adaptive immune functions. Thus elderly individuals usually present chronic low-level inflammation, higher infection rates and chronic diseases. A study of alterations in the immune system during aging could provide a potentially useful biomarker for the evaluation of immune senescence treatment. The immune system is the result of the interplay between innate and adaptive immunity, yet the impact of aging on this function is unclear. In this article the function of the immune system during aging is explored.
Subject(s)
Humans , Aged , Aged, 80 and over , Immunosenescence/physiology , Immunosenescence/immunology , Immune System/physiopathology , Immune System Diseases/physiopathology , T-Lymphocytes/physiology , Age FactorsSubject(s)
Dermatitis, Atopic/therapy , Food Hypersensitivity/therapy , Child , Dermatitis, Atopic/etiology , Dermatitis, Atopic/immunology , Desensitization, Immunologic , Diet , Filaggrin Proteins , Food Hypersensitivity/diagnosis , Food Hypersensitivity/etiology , Food Hypersensitivity/immunology , Humans , Immunoglobulin E/blood , Immunotherapy , Intermediate Filament Proteins/genetics , Mutation , Prognosis , Risk Factors , Skin Tests , T-Lymphocytes/physiologyABSTRACT
Dopamine receptors have been described in T-cells, however their signalling pathways coupled remain unknown. Since cAMP and ERKs play key roles regulating T-cell physiology, we aim to determine whether cAMP and ERK1/2-phosphorylation are modulated by dopamine receptor 3 (D3R) and D5R, and how this modulation affects CD4(+) T-cell activation and differentiation. Our pharmacologic and genetic evidence shows that D3R-stimulation reduced cAMP levels and ERK2-phosphorylation, consequently increasing CD4(+) T-cell activation and Th1-differentiation, respectively. Moreover, D5R expression reinforced TCR-triggered ERK1/2-phosphorylation and T-cell activation. In conclusion, these findings demonstrate how D3R and D5R modulate key signalling pathways affecting CD4(+) T-cell activation and Th1-differentiation.
Subject(s)
CD4 Antigens/metabolism , Cell Differentiation/physiology , Cyclic AMP/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Receptors, Dopamine D3/metabolism , Receptors, Dopamine D5/metabolism , T-Lymphocytes/physiology , Animals , Cell Differentiation/drug effects , Cell Differentiation/genetics , Dopamine Agents/pharmacology , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Activation/genetics , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Interleukin-2 Receptor alpha Subunit/metabolism , Ionomycin/pharmacology , Lymphocyte Activation/drug effects , Lymphocyte Activation/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Phosphorylation/drug effects , Phosphorylation/genetics , Receptors, Dopamine D3/genetics , Receptors, Dopamine D5/genetics , Signal Transduction/drug effects , Signal Transduction/genetics , T-Lymphocytes/drug effectsABSTRACT
Angiotensin II (Ang II) plays an important role in the regulation of the T-cell response during inflammation. However, the cellular mechanisms underlying the regulation of lymphocytes under physiologic conditions have not yet been studied. Here, we tested the influence of Ang II on T-cell migration using T cells from BALB/c mice. The results obtained in vivo showed that when Ang II production or the AT1 receptor were blocked, T-cell counts were enhanced in blood but decreased in the spleen. The significance of these effects was confirmed by observing that these cells migrate, through fibronectin to Ang II via the AT1 receptor. We also observed a gradient of Ang II from peripheral blood to the spleen, which explains its chemotactic effect on this organ. The following cellular mechanisms were identified to mediate the Ang II effect: upregulation of the chemokine receptor CCR9; upregulation of the adhesion molecule CD62L; increased production of the chemokines CCL19 and CCL25 in the spleen. These results indicate that the higher levels of Ang II in the spleen and AT1 receptor activation contribute to migration of naive T cells to the spleen, which expands our understanding on how the Ang II/AT1 receptor axis contributes to adaptive immunity.
Subject(s)
Angiotensin II/metabolism , Renin-Angiotensin System/physiology , T-Lymphocytes/physiology , Adaptive Immunity , Angiotensin II/pharmacology , Animals , Cell Movement , Cells, Cultured , Chemokine CCL19/metabolism , Chemokines, CC/metabolism , L-Selectin/metabolism , Male , Mice, Inbred BALB C , Receptor, Angiotensin, Type 1/metabolism , Receptors, CCR/metabolism , Receptors, CCR7/metabolism , Receptors, Lymphocyte Homing/metabolism , Spleen/cytology , Spleen/immunology , Spleen/metabolism , T-Lymphocytes/immunologyABSTRACT
Background: In colorectal cancer (CRC) patients, lymphocyte infiltration (LI) and microsatellite instability (MSI) have been associated with better prognosis. Aim: To analyze the association between components of LI (CD3/CD4/CD8/CD45R0/FoxP3) and MSI status with metastatic stages in CRC patients. Material and Methods: Prospective study of 109 patients diagnosed with CRC. The expression of CD3, CD4, CD8, CD45R0 and FoxP3 markers, was evaluated by immunohistochemical analysis, and tumors were classified into negative, low and intense expression. The MSI was assessed with seven markers amplified by PCR from normal and tumoral DNA. Tumors were grouped in MSS (stable)/MSI-low and MSI-high. Statistical analysis was performed with Fischer's exact test. Results: 29 percent, 28 percent, 12 percent and 86 percent of tumors exhibits intense expression of CD3+, CD4+, CD8+ and CD45RO+ lymphocytes, respectively. 84 percent of the tumors presented MSS/ MSI-low and 16 percent had MSI-high. Tumors that show a high density of T cells (CD3+, CD4+ y CD45R0+) are associated with early stage tumors (I and II) (p = 0.023; p = 0.030 and p = 0.003, respectively). Additionally, there was a significant association between the MSS/MSI-low tumors and a reduced ability to recruit CD8+ cytotoxic T lymphocytes (p = 0.037) and CD3+ (p = 0.064). Conclusion: There is an association between high densities of CD3+, CD4+ and CD45RO+ lymphocytes and non-metastatic tumors. In addition, MSS/ MSI-low tumors are associated with a lower recruitment of CD8+ and CD3+ lymphocytes.
Introducción: En el cáncer colorrectal (CCR), se sugiere que un mejor pronóstico podría asociarse a una respuesta inmune antitumoral (del huésped) y/o a la presencia de una alta inestabilidad microsatelital (MSI). Objetivo: Determinar si los niveles de expresión de los marcadores de linfocitos T (CD3/CD4/CD8/ CD45RO/FoxP3) y el estado de MSI se asocian a estadios metastásicos en pacientes con CCR. Material y Método: Estudio prospectivo de 109 pacientes con diagnóstico de CCR. El análisis de expresión de los marcadores CD3/CD4/CD8/CD45RO/FoxP3 fue realizado por inmunohistoquímica; los tumores fueron clasificados en negativo, débil e intenso. La MSI fue evaluada con siete marcadores amplificados desde ADN normal y tumoral; los tumores fueron agrupados en: MSS (estable)/MSI-baja y MSI-alta. El análisis estadístico fue realizado con el test exacto de Fischer. Resultados: Una intensa expresión de los marcadores CD3+, CD4+, CD8+ y CD45RO+, fue observada en el 29 por ciento, 28 por ciento, 12 por ciento y 86 por ciento de los tumores, respectivamente. El 16 por ciento de los tumores presentó MSI-alta. Los tumores que presentan una alta densidad de linfocitos T (CD3+, CD4+ y CD45RO+) se asocian a estadios tempranos I-II (p = 0,023; p = 0,030 y p = 0,003, respectivamente). Adicionalmente, se identificó una asociación estadística significativa entre los tumores con MSS/MSI-baja y una menor capacidad de reclutar linfocitos T citotóxicos CD8+ (p = 0,037) y totales CD3+ (p = 0,064). Conclusión: Existe una asociación entre altas densidades de linfocitos T CD3+, CD4+ y CD45RO+ y tumores con estadios no metastásicos. Además, tumores con MSS/MSI-baja se asocian a un menor reclutamiento de linfocitos T CD8+ y CD3+.
Subject(s)
Humans , Male , Adult , Female , Middle Aged , Aged, 80 and over , Colorectal Neoplasms/genetics , Colorectal Neoplasms/immunology , Colorectal Neoplasms/pathology , Lymphocyte Activation/physiology , Biomarkers, Tumor , Cohort Studies , Follow-Up Studies , Immunohistochemistry , Lymphocytes, Tumor-Infiltrating , T-Lymphocytes/physiology , Microsatellite Instability , Neoplasm Metastasis , Neoplasm Staging , Survival AnalysisABSTRACT
Nos últimos dez anos a incidência do câncer tem sido mundialmente alarmante, constituindo um grave problema de saúde pública com expectativas de aumento para as próximas décadas. Estudos epidemiológicos no Brasil demonstraram que o câncer de maior prevalência é o de próstata, entretanto o câncer de pele tem impactado de forma significativa a população em geral. Dentre os principais tipos de câncer de pele, o melanoma é o que mais causa óbitos devido a sua alta capacidade de metástase. Vários fatores estão envolvidos no desenvolvimento do melanoma, entretanto interações entre as células neoplásicas e as células normais presentes no local onde o tumor se desenvolve é o foco de estudo da maioria dos centros de pesquisa em câncer. Assim, nesta revisão são apresentados os principais achados descritos nos últimos dez anos em relação às interações das células neoplásicas com os componentes do microambiente tumoral no modelo de melanoma.
The last ten years, the incidence of cancer has been globally alarming constituting a serious public health problem with increasing expectations for the coming decades. Epidemiological studies in Brazil showed that, the most prevalent of all cancers is prostate cancer, however skin cancer has impacted significantly the general population. Among the main types of skin cancer, melanoma causes more deaths due to its high ability to metastasize. Several factors are involved in the development of melanoma, however interactions between the neoplastic cells and the normal cells at the site where the tumor develops is the aim of many research centers in cancer. Thus, this review presents the main findings described in the last ten years in relation to the interactions between cancer cells and the components of the tumor microenvironment in melanoma model.
Subject(s)
Melanoma/physiopathology , Tumor Microenvironment/physiology , Skin Neoplasms/physiopathology , B-Lymphocytes/physiology , T-Lymphocytes/physiology , Macrophages/physiologyABSTRACT
Nos últimos dez anos a incidência do câncer tem sido mundialmente alarmante, constituindo um grave problema de saúde pública com expectativas de aumento para as próximas décadas. Estudos epidemiológicos no Brasil demonstraram que o câncer de maior prevalência é o de próstata, entretanto o câncer de pele tem impactado de forma significativa a população em geral. Dentre os principais tipos de câncer de pele, o melanoma é o que mais causa óbitos devido a sua alta capacidade de metástase. Vários fatores estão envolvidos no desenvolvimento do melanoma, entretanto interações entre as células neoplásicas e as células normais presentes no local onde o tumor se desenvolve é o foco de estudo da maioria dos centros de pesquisa em câncer. Assim, nesta revisão são apresentados os principais achados descritos nos últimos dez anos em relação às interações das células neoplásicas com os componentes do microambiente tumoral no modelo de melanoma.(AU)
The last ten years, the incidence of cancer has been globally alarming constituting a serious public health problem with increasing expectations for the coming decades. Epidemiological studies in Brazil showed that, the most prevalent of all cancers is prostate cancer, however skin cancer has impacted significantly the general population. Among the main types of skin cancer, melanoma causes more deaths due to its high ability to metastasize. Several factors are involved in the development of melanoma, however interactions between the neoplastic cells and the normal cells at the site where the tumor develops is the aim of many research centers in cancer. Thus, this review presents the main findings described in the last ten years in relation to the interactions between cancer cells and the components of the tumor microenvironment in melanoma model.(AU)
Subject(s)
Melanoma/physiopathology , Tumor Microenvironment/physiology , Skin Neoplasms/physiopathology , Macrophages/physiology , T-Lymphocytes/physiology , B-Lymphocytes/physiologyABSTRACT
Osteoblastoma is a benign neoplasia and is uncommon in the jaws. In some cases, this lesion presents extremely aggressive local characteristics and is termed aggressive osteoblastoma. Because the clinical, radiographic and histopathologic characteristics are similar to those of a variety of benign and malignant tumors, it poses a diagnostic dilemma. This report presents a case of an aggressive osteoblastoma in the mandible and discusses the differential diagnosis of this lesion. A 13-year-old white male sought the Stomatology Clinic at the State University of Paraíba, Campina Grande, PB, Brazil, complaining of asymptomatic swelling on the left side of his face. Cone-beam computerized tomography showed a multilocular, hypodense bone lesion, located in the body of the left mandible and lower third of the ascending ramus. The initial diagnostic hypothesis was juvenile ossifying fibroma or osteosarcoma. After histopathologic examination, the final diagnosis was aggressive osteoblastoma. Surgical resection with a safety margin was performed. There was no evidence of recurrence after a follow-up period of 4 years.
O osteoblastoma é uma neoplasia benigna e incomum nos maxilares. Em alguns casos esta lesão apresenta características locais extremamente agressivas, sendo denominada osteoblastoma agressivo. Devido às características clínicas, radiográficas e histopatológicas serem similares a uma variedade de tumores benignos e malignos, o seu diagnóstico é um dilema. Este relato apresenta o caso de um osteoblastoma agressivo na mandíbula e discute o diagnóstico diferencial desta lesão. Paciente, branco, 13 anos de idade, foi atendido na Clínica de Estomatologia da Universidade Estadual da Paraíba, Campina Grande, PB, Brasil, queixando-se de aumento de volume assintomático do lado esquerdo de sua face. A tomografia computadorizada de feixe cônico revelou uma lesão óssea hipodensa multilocular, localizada no corpo do lado esquerdo da mandíbula e no terço inferior do ramo ascendente da mandíbula. A hipótese diagnóstica foi de fibroma ossificante juvenil e osteosarcoma. Após exame histopatológico, o diagnóstico final foi osteoblastoma agressivo. Foi realizada ressecção cirúrgica com margem de segurança. Não houve sinais de recorrência após 4 anos de acompanhamento.
Subject(s)
Animals , Humans , Mice , Apoptosis/physiology , Carrier Proteins/metabolism , Mitochondrial Proteins/metabolism , Antibodies/metabolism , Antibodies/pharmacology , /metabolism , B-Lymphocytes/physiology , Caspase 9 , Cells, Cultured , Carrier Proteins/genetics , Caspases/metabolism , Enzyme Activation , Embryo, Mammalian/physiology , Gene Targeting , Intracellular Signaling Peptides and Proteins , Mice, Knockout , Mitochondrial Proteins/genetics , Survival Rate , Stem Cells/cytology , Stem Cells/metabolism , T-Lymphocytes/physiologyABSTRACT
Frequencies of circulating T cells producing IFN-γ, TNF-α, and IL-2, and percentages of T cells proliferating after stimulation with rotavirus (RV), tetanus toxoid, and influenza were evaluated in PBMC derived from healthy adults and children. In addition, the potential anergic state of RV-specific T cells was analyzed by stimulation of PBMC with RV antigen in the presence of three anergy inhibitors (rIL-2, rIL-12, or DGKα-i). The quality and magnitude of RV-T cell responses were significantly lower than those of tetanus toxoid and influenza antigens. RV-CD4 T cell response was enriched in monofunctional IFN-γ(+) cells, while influenza-CD4 and tetanus toxoid-CD4 T cell responses were enriched in multifunctional T cells. Moreover, rIL-2--unlike rIL-12 or DGKα-i--increased the frequencies of RV-CD4 TNF-α(+), CD4 IFN-γ(+), and CD8 IFN-γ(+) cells. Thus, circulating RV-T cells seem to have a relatively poor functional profile that may be partially reversed in vitro by the addition of rIL-2.